Furthermore, diffuse large B-cell lymphoma growth can be blocked by inhibition of SETD2 in the case of EZH2 hypermorphic mutation-mediated drug addiction to PRC2 inhibitors21. Here, EZH2 is linked to diffuse large B-cell lymphoma.